List of works - Emilio F. Espejo

A Rare Paronychia with Superinfection with <i>Prevotella bivia</i> and <i>Staphylococcus haemolyticus</i>: The Importance of Early Microbiological Diagnosis

scientific article published on 29 November 2020

Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion

scientific article published on 21 April 2005

Alteration of neuropathic and visceral pain in female C57BL/6J mice lacking the PPAR-α gene.

scientific article published on 22 February 2012

Analysis of neurotrophic and antioxidant factors related to midbrain dopamine neuronal loss and brain inflammation in the cerebrospinal fluid of the elderly

scientific article published on 19 May 2018

Antiparkinsonian trophic action of glial cell line-derived neurotrophic factor and transforming growth factor β1 is enhanced after co-infusion in rats.

scientific article published on 14 August 2010

Behavioral study in rats of paired accumbens-lesioned residents and intact intruders

scientific article published in May 1990

Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism

scientific article

Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies

scientific article published in March 2007

Cells of the sympathoadrenal lineage: Biological properties as donor tissue for cell-replacement therapies for Parkinson's disease

scientific article published on 02 March 2005

Does the Cerebrospinal Fluid Reflect Altered Redox State But Not Neurotrophic Support Loss in Parkinson's Disease?

scientific article published on 11 August 2015

Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome

scientific article

Effects of acute and repeated cocaine on markers for neural plasticity within the mesolimbic system in rats

scientific article published on 10 June 2014

Effects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice

scientific article published in May 2010

Effects on turning of microinjections into basal ganglia of D(1) and D(2) dopamine receptors agonists and the cannabinoid CB(1) antagonist SR141716A in a rat Parkinson's model

scientific article

Endocannabinoid-mediated synaptic plasticity and substance use disorders

scientific article published on 08 March 2019

Excess amounts of 3-iodo-l-tyrosine induce Parkinson-like features in experimental approaches of Parkinsonism

scholarly article by Emilio F. Espejo & Cristian Bis-Humbert published July 2018 in NeuroToxicology

Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function

scientific article published in June 2004

Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.

scientific article

Grafts of extra-adrenal chromaffin cells as aggregates show better survival rate and regenerative effects on parkinsonian rats than dispersed cell grafts

scientific article

Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors.

scientific article published on 16 February 2010

Is there a halo-enzymopathy in Parkinson's disease?

scientific article published on 02 April 2019

May serum levels of advanced oxidized protein products serve as a prognostic marker of disease duration in patients with idiopathic Parkinson's disease?

scientific article published on 7 December 2012

May the thyroid gland and thyroperoxidase participate in nitrosylation of serum proteins and sporadic Parkinson's disease?

scientific article

Mice lacking the peroxisome proliferator-activated receptor α gene present reduced number of dopamine neurons in the substantia nigra without altering motor behavior or dopamine neuron decline over life.

scientific article

Morphophysiology of the Zuckerkandl's paraganglion: effects of dexamethasone and aging

scientific article published on 22 January 2009

Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia

scientific article published on 19 September 2018

Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARα receptor-independent mechanism.

scientific article published on 19 November 2012

Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons.

scientific article

Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors

scientific article

Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia

scientific article published on 29 July 2018

Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies.

scientific article published on February 2004

Psychostimulant Drugs and Neuroplasticity

QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.

scientific article published on 11 May 2006

Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes

scientific article published in June 2010

Role for D-serine within the ventral tegmental area in the development of cocaine's sensitization.

scientific article

Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors

scientific article

Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor

scientific article published on 16 April 2004

Serum from Parkinson’s disease patients presents excess of protein halogenation and nitrosylation, with anomalous nitrosylation of serum α-synuclein as potentially etiological factor

scientific article published on 13 September 2013

Structure of the mouse behaviour on the elevated plus-maze test of anxiety

scientific article published in June 1997

The absence of a functional peroxisome proliferator-activated receptor-alpha gene in mice enhances motor sensitizing effects of morphine, but not cocaine.

scientific article published on 18 August 2009

The neurobiology of psychostimulant addiction

scientific article published in August 2006

The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism

scientific article published on 29 October 2013

The transient receptor potential vanilloid-1 is localized at excitatory synapses in the mouse dentate gyrus

scientific article published on 01 February 2014

WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

scientific article published on 21 May 2009

[Is the fundus striati a new limbic-motor interphase?]

scientific article published on 01 April 2000

List of works by Emilio F. Espejo

A Rare Paronychia with Superinfection with <i>Prevotella bivia</i> and <i>Staphylococcus haemolyticus</i>: The Importance of Early Microbiological Diagnosis

Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion

Alteration of neuropathic and visceral pain in female C57BL/6J mice lacking the PPAR-α gene.

Analysis of neurotrophic and antioxidant factors related to midbrain dopamine neuronal loss and brain inflammation in the cerebrospinal fluid of the elderly

Antiparkinsonian trophic action of glial cell line-derived neurotrophic factor and transforming growth factor β1 is enhanced after co-infusion in rats.

Behavioral study in rats of paired accumbens-lesioned residents and intact intruders

Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism

Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies

Cells of the sympathoadrenal lineage: Biological properties as donor tissue for cell-replacement therapies for Parkinson's disease

Does the Cerebrospinal Fluid Reflect Altered Redox State But Not Neurotrophic Support Loss in Parkinson's Disease?

Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome

Effects of acute and repeated cocaine on markers for neural plasticity within the mesolimbic system in rats

Effects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice

Effects on turning of microinjections into basal ganglia of D(1) and D(2) dopamine receptors agonists and the cannabinoid CB(1) antagonist SR141716A in a rat Parkinson's model

Endocannabinoid-mediated synaptic plasticity and substance use disorders

Excess amounts of 3-iodo-l-tyrosine induce Parkinson-like features in experimental approaches of Parkinsonism

Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function

Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.

Grafts of extra-adrenal chromaffin cells as aggregates show better survival rate and regenerative effects on parkinsonian rats than dispersed cell grafts

Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors.

Is there a halo-enzymopathy in Parkinson's disease?

May serum levels of advanced oxidized protein products serve as a prognostic marker of disease duration in patients with idiopathic Parkinson's disease?

May the thyroid gland and thyroperoxidase participate in nitrosylation of serum proteins and sporadic Parkinson's disease?

Mice lacking the peroxisome proliferator-activated receptor α gene present reduced number of dopamine neurons in the substantia nigra without altering motor behavior or dopamine neuron decline over life.

Morphophysiology of the Zuckerkandl's paraganglion: effects of dexamethasone and aging

Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia

Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARα receptor-independent mechanism.

Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons.

Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors

Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia

Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies.

Psychostimulant Drugs and Neuroplasticity

QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.

Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes

Role for D-serine within the ventral tegmental area in the development of cocaine's sensitization.

Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors

Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor

Serum from Parkinson’s disease patients presents excess of protein halogenation and nitrosylation, with anomalous nitrosylation of serum α-synuclein as potentially etiological factor

Structure of the mouse behaviour on the elevated plus-maze test of anxiety

The absence of a functional peroxisome proliferator-activated receptor-alpha gene in mice enhances motor sensitizing effects of morphine, but not cocaine.

The neurobiology of psychostimulant addiction

The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism

The transient receptor potential vanilloid-1 is localized at excitatory synapses in the mouse dentate gyrus

WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

[Is the fundus striati a new limbic-motor interphase?]